Vital Group Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

Date: December 1, 2016
Pages: 50
Price:
US$ 499.00
Vital Group Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default),
Hard Copy Mail Delivery (+US$ 190.00)
ID: V94BCE382D4BEN
Leaflet:

Download PDF Leaflet

Vital Group Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Vital Group Holdings Limited Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between Vital Group Holdings Limited and its competitors. This provides our Clients with a clear understanding of Vital Group Holdings Limited position in the Pharmaceuticals and Biotechnology Industry.

  • The report contains detailed information about Vital Group Holdings Limited that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
  • Another part of the report is a SWOT-analysis carried out for Vital Group Holdings Limited. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
  • The Vital Group Holdings Limited financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
  • In the part that describes Vital Group Holdings Limited competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
  • Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Vital Group Holdings Limited business.

About Vital Group Holdings Limited

Vital BioTech Holdings Ltd (the company) was established in 1998. Vital Biotech is a bio-technology company that efficiently creates and commercialises therapeutics.

The company's proprietary platform technologies developed by its Australian R&D centre are Protein Stabilisation and Delivery (PSD); Vaccine Stabilisation; and Skin Drug Delivery System (SDDS).

PROTEIN STABILISATION AND DELIVERY (PSD)

Vital BioTech has developed a patented platform technology for protein stabilization and non-injection delivery which can be applied to proteins, enzymes and probiotics. This novel process (known as micro-bioencapsulation) takes place within an air stream or nitrogen environment at 38-40¡ãC. The biological material in the liquid formulation is instantaneously immobilised onto the seed particles being fluidised. The process can yield between 2 and 3000kg of free flowing product. The encapsulated products are biologically stable and can be administered in more convenient dose forms - sublingual or nasal presentations instead of parenteral or nebulised. Sublingual and nasal delivery of products provides therapeutic responses with reduced side effects or degradation. Room temperature storage time is substantially extended, avoiding the need for refrigeration and short product expiry. The micro-bioencapsulation process avoids the expensive freeze drying process, resulting in a faster, higher yield and a lower cost production process.

Examples of biological products evaluated in the micro-bioencapsulated technology are:

Proteins: Interferon-¦Á, Hyaluronic acid, Erythropoietin (EPO), Lysozyme/Muramidase, Bromelain o Beta-galactosidase, Interleukin-1b peptide, Enzyme growth promotant: Protease, Amylase, Cellulase, Lipase and Porcine somatotropin (growth hormone).

Bacteria: Lactobacilli and Bifidus.

Viruses (Avian): Newcastle Disease (ND), Infectious Bursal Disease (IBD) and Infectious Bronchitis (H120).

VACCINE STABILISATION

An extension of the PSD technology applied to live viruses. This technology allows for the replacement of freeze drying of the vaccine, extend the product shelf life at room temperature and reduce the requirement for refrigerated logistic and storage conditions.

Example of Viruses (Avian): Newcastle Disease (ND), Infectious Bursal Disease (IBD) and Infectious Bronchitis (H120).

SKIN DRUG DELIVERY SYSTEM (SDDS)

Polymer membrane technology for spray-on skin patch delivery system include Water proof, Flexible, Porous, Self disintegrating, Sustained release and Non-aerosol.

Existing products marketed in the Peoples Republic of China (PRC) are Opin, Osteoform and Spray-On Bandage.

Opin: interferon tablet for vaginal delivery for treatment of chronic erosive cervicitis.

New Products under development include: nasal interferon spray and sublingual EPO.

Osteoform: is a Amino acid chelated Calcium, used for prevention and treatment of Osteoporosis and calcium deficiency.

Spray-On Bandage: utilises the technology as; artificial skin membrane, vehicle for the delivery of antibacterials, applicable to chemical pharmaceutical products and is an Extension of technology to any-fungal, anti-inflammatory spray.


The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.

RESEARCH METHODOLOGY

DISCLAIMER

1. VITAL GROUP HOLDINGS LIMITED COMPANY PROFILE

1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History

2. VITAL GROUP HOLDINGS LIMITED BUSINESS OVERVIEW

2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units

3. VITAL GROUP HOLDINGS LIMITED SWOT ANALYSIS

3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats

4. VITAL GROUP HOLDINGS LIMITED FINANCIAL ANALYSIS

4.1. Financial Statements
  4.1.1. Income Statement
  4.1.2. Balance Sheet
  4.1.3. Cash Flow
4.2. Financial Ratios
  4.2.1. Profitability
  4.2.2. Margin Analysis
  4.2.3. Asset Turnover
  4.2.4. Credit Ratios
  4.2.5. Long-Term Solvency
  4.2.6. Growth Over Prior Year
  4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot

5. VITAL GROUP HOLDINGS LIMITED COMPETITORS AND INDUSTRY ANALYSIS

5.1. Vital Group Holdings Limited Direct Competitors
5.2. Comparison of Vital Group Holdings Limited and Direct Competitors Financial Ratios
5.3. Comparison of Vital Group Holdings Limited and Direct Competitors Stock Charts
5.4. Vital Group Holdings Limited Industry Analysis
  5.4.1. Pharmaceuticals and Biotechnology Industry Snapshot
  5.4.2. Vital Group Holdings Limited Industry Position Analysis

6. VITAL GROUP HOLDINGS LIMITED NEWS & EVENTS

6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events

7. VITAL GROUP HOLDINGS LIMITED EXPERTS REVIEW1

7.1. Experts Opinion
7.2. Experts Estimates

8. VITAL GROUP HOLDINGS LIMITED ENHANCED SWOT ANALYSIS2

9. HONG KONG PESTEL ANALYSIS2

9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors

10. VITAL GROUP HOLDINGS LIMITED IFE, EFE, IE MATRICES2

10.1. Internal Factor Evaluation Matrix
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix

11. VITAL GROUP HOLDINGS LIMITED PORTER FIVE FORCES ANALYSIS2

12. VITAL GROUP HOLDINGS LIMITED VRIO ANALYSIS2


APPENDIX: RATIO DEFINITIONS


LIST OF TABLES

Vital Group Holdings Limited Key Facts
Profitability
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Vital Group Holdings Limited Key Executives
Key Executives Biographies1
Key Executives Compensations1
Vital Group Holdings Limited Major Shareholders
Vital Group Holdings Limited History
Vital Group Holdings Limited Products
Revenues by Segment
Revenues by Region
Vital Group Holdings Limited Offices and Representations
Vital Group Holdings Limited SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Vital Group Holdings Limited Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Vital Group Holdings Limited Capital Market Snapshot
Vital Group Holdings Limited Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Pharmaceuticals and Biotechnology Industry Statistics
Vital Group Holdings Limited Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Vital Group Holdings Limited Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Historical Surprises1
Revenue Estimates Trend1
Earnings Estimates Trend1
Revenue Revisions1

LIST OF FIGURES

Vital Group Holdings Limited Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Vital Group Holdings Limited 1-year Stock Charts
Vital Group Holdings Limited 5-year Stock Charts
Vital Group Holdings Limited vs. Main Indexes 1-year Stock Chart
Vital Group Holdings Limited vs. Direct Competitors 1-year Stock Charts
Vital Group Holdings Limited Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

  • How to use the strengths to take advantage of the opportunities?
  • How to use the strengths to reduce likelihood and impact of the threats?
  • How to overcome the weaknesses that obstruct taking advantage of the opportunities?
  • How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a project plan to improve its business performance.


PESTEL Analysis

PESTEL (also termed as PESTLE) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

  • Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
  • Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
  • Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
  • Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
  • Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
  • Legal – What laws and legislation will exert influence on the style the business is carried out?

IFE, EFE, IE Matrices

The Internal Factor Evaluation matrix (IFE matrix) is a strategic management tool helping audit or evaluate major weaknesses and strengths in a business’s functional areas. In addition, IFE matrix serves as a basis for identifying and assessing relationships amongst those areas. The IFE matrix is utilised in strategy formulation.

The External Factor Evaluation matrix (EFE matrix) is a tool of strategic management that is typically utilised to assess current market conditions. It is an ideal instrument for visualising and prioritising the threats and opportunities a firm is facing.

The essential difference between the above mentioned matrices lies in the type of factors incorporated in the model; whilst the latter is engaged in internal factors, the former deals exceptionally with external factors – those exposed to social, political, economic, legal, etc. external forces.

Being a continuation of the EFE matrix and IFE matrix models, the Internal External matrix (IE matrix) rests upon an investigation of external and internal business factors integrated into one suggestive model.


Porter Five Forces Analysis

The Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions:

  1. What composes a threat of substitute products and services?
  2. Is there a threat of new competitors entering the market?
  3. What is the intensity of competitive rivalry?
  4. How big is the bargaining power of buyers?
  5. How significant is the bargaining power of suppliers?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

  • Tangible resources
    • Financial
    • Physical
    • Technological
    • Organizational
  • Intangible resources
    • Human
    • Innovation and Creativity
    • Reputation
  • Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

  • Valuable?
  • Rare?
  • Costly to imitate?
  • Organized properly?
Skip to top


Ask Your Question

Vital Group Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: